Analysen zu GSK PLC Registered Shs
| 07.01.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | GSK Outperform | Bernstein Research | |
| 18.12.24 | GSK Hold | Deutsche Bank AG | |
| 18.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 17.12.24 | GSK Hold | Deutsche Bank AG | |
| 11.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 11.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.12.24 | GSK Hold | Jefferies & Company Inc. | |
| 06.12.24 | GSK Hold | Deutsche Bank AG | |
| 05.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 03.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.12.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 15.11.24 | GSK Hold | Deutsche Bank AG | |
| 14.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 12.11.24 | GSK Hold | Jefferies & Company Inc. | |
| 01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | GSK Buy | Deutsche Bank AG | |
| 31.10.24 | GSK Neutral | UBS AG | |
| 31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | GSK Neutral | UBS AG | |
| 30.10.24 | GSK Outperform | Bernstein Research | |
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.10.24 | GSK Neutral | UBS AG | |
| 11.10.24 | GSK Buy | Deutsche Bank AG | |
| 11.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.10.24 | GSK Buy | Deutsche Bank AG | |
| 10.10.24 | GSK Neutral | UBS AG | |
| 10.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 09.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.10.24 | GSK Buy | Deutsche Bank AG | |
| 09.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 08.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 03.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 17.09.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 16.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 11.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 09.09.24 | GSK Buy | Deutsche Bank AG | |
| 16.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 15.08.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 02.08.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.08.24 | GSK Halten | DZ BANK |
Aktuelle Aktienanalysen
| 01.06.26 | Meta Platforms Outperform | RBC Capital Markets | |
| 01.06.26 | CTS Eventim Buy | Deutsche Bank AG | |
| 01.06.26 | UNIQA Insurance kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.06.26 | FedEx Buy | Goldman Sachs Group Inc. | |
| 01.06.26 | LEG Immobilien Neutral | Goldman Sachs Group Inc. | |
| 01.06.26 | Grand City Properties Neutral | Goldman Sachs Group Inc. | |
| 01.06.26 | Aroundtown Neutral | Goldman Sachs Group Inc. | |
| 01.06.26 | Vonovia Buy | Goldman Sachs Group Inc. | |
| 01.06.26 | easyJet Overweight | Barclays Capital | |
| 01.06.26 | Fresenius Medical Care Sell | UBS AG | |
| 01.06.26 | BioNTech Buy | Jefferies & Company Inc. | |
| 01.06.26 | Pfizer Buy | Jefferies & Company Inc. | |
| 01.06.26 | Inditex Outperform | RBC Capital Markets | |
| 01.06.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 01.06.26 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 01.06.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.06.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.06.26 | easyJet Outperform | RBC Capital Markets | |
| 01.06.26 | easyJet Underweight | JP Morgan Chase & Co. | |
| 01.06.26 | ASML NV Hold | Jefferies & Company Inc. | |
| 01.06.26 | AIXTRON Buy | Jefferies & Company Inc. | |
| 01.06.26 | Infineon Buy | Jefferies & Company Inc. | |
| 29.05.26 | Beiersdorf Neutral | JP Morgan Chase & Co. | |
| 29.05.26 | Saint-Gobain Kaufen | DZ BANK | |
| 29.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.05.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.05.26 | Daimler Truck Buy | Jefferies & Company Inc. | |
| 29.05.26 | National Grid Sector Perform | RBC Capital Markets | |
| 29.05.26 | CTS Eventim Kaufen | DZ BANK | |
| 29.05.26 | Rio Tinto Kaufen | DZ BANK | |
| 29.05.26 | GSK Neutral | UBS AG | |
| 29.05.26 | AIXTRON Hold | Deutsche Bank AG | |
| 29.05.26 | LANXESS Hold | Deutsche Bank AG | |
| 29.05.26 | Brenntag Buy | Deutsche Bank AG | |
| 29.05.26 | Inditex Equal Weight | Barclays Capital | |
| 29.05.26 | CTS Eventim Buy | UBS AG | |
| 29.05.26 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 29.05.26 | LEG Immobilien Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.05.26 | Pernod Ricard Neutral | UBS AG | |
| 29.05.26 | Knorr-Bremse Buy | Deutsche Bank AG | |
| 29.05.26 | Pernod Ricard Neutral | UBS AG | |
| 29.05.26 | BASF Buy | Deutsche Bank AG | |
| 29.05.26 | SFC Energy Buy | Deutsche Bank AG | |
| 29.05.26 | LANXESS Halten | DZ BANK | |
| 29.05.26 | Alphabet A Overweight | Barclays Capital | |
| 29.05.26 | RWE Overweight | Barclays Capital | |
| 29.05.26 | Commerzbank Overweight | Barclays Capital | |
| 29.05.26 | CTS Eventim Overweight | Barclays Capital | |
| 29.05.26 | CTS Eventim Outperform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.